Clinical Trial: Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis
Brief Summary:
An evaluation of the safety and efficacy of the calcineurin inhibitor, pimecrolimus cream 1%, in adult patients with perioral dermatitis.
This study is not enrolling patients in the United States.
Detailed Summary:
Sponsor: Novartis
Current Primary Outcome: Reduction of the Perioral Dermatitis Severity Index
Original Primary Outcome:
Current Secondary Outcome:
- Time to disease recurrence
- Response rates
- Patient's quality of life assessment
- Patient's disease severity assessment
Original Secondary Outcome:
Information By: Novartis
Dates:
Date Received: October 3, 2005
Date Started: September 2005
Date Completion:
Last Updated: January 15, 2008
Last Verified: January 2008